Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
IQVIA Holdings NYSE:IQV |
28,03 B | 11,60% | 5/6 | 6,09% | 36,77% | 43,75% | DOWN |
|
Exact Sciences NasdaqCM:EXAS |
20,03 B | 14,66% | 4/6 | 12,88% | -123,40% | 0,09% | UP |
|
PPD NasdaqGM:PPD |
16,61 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | UP |
|
Medpace Holdings NasdaqGS:MEDP |
12,97 B | 29,26% | 6/6 | 12,33% | 6,28% | 9,43% | DOWN |
|
PRA Health Sciences NasdaqGM:PRAH |
10,71 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Charles River Laboratories International NYSE:CRL |
7,78 B | 5,81% | 5/6 | 1,92% | 30,57% | 24,68% | DOWN |
|
Syneos Health NasdaqGM:SYNH |
2,64 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Disc Medicine NasdaqGM:IRON |
2,26 B | 0,00% | 1/3 | 0,00% | 0,00% | 69,18% | DOWN |
|
Azenta NasdaqGS:AZTA |
0,94 B | -8,84% | 5/6 | 24,93% | 61,64% | 95,60% | DOWN |
|
Fortrea Holdings NasdaqGS:FTRE |
0,91 B | -28,00% | 0/2 | 39,52% | 36,13% | 43,59% | DOWN |
|
Cytek Biosciences NasdaqGS:CTKB |
0,61 B | -45,22% | 2/4 | 159,77% | 0,00% | 22,08% | DOWN |
|
Maravai LifeSciences Holdings NasdaqGS:MRVI |
0,45 B | -23,05% | 0/0 | 96,87% | -185,40% | 46,58% | DOWN |
|
Ginkgo Bioworks Holdings NYSE:DNA |
0,41 B | -30,24% | 2/4 | -12,08% | 36,59% | 28,76% | DOWN |
|
Frontage Holdings SEHK:1521 |
2,21 B | 62,51% | 4/6 | 8,96% | 95,68% | -10,09% | DOWN |
|
Seer NasdaqGS:SEER |
0,10 B | 0,00% | 0/0 | -1,32% | -64,26% | -100,00% | DOWN |
|
Bioqual OTCPK:BIOQ |
0,04 B | 0,00% | 1/2 | 0,00% | 0,00% | -100,00% | DOWN |
|
Research Frontiers NasdaqCM:REFR |
0,03 B | 14,09% | 2/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
Inotiv NasdaqCM:NOTV |
0,01 B | 22,25% | 1/4 | 3,24% | 92,02% | 884,85% | DOWN |
|
BNB Plus NasdaqCM:BNBX |
0,00 B | -41,07% | 1/4 | 245,11% | 97,84% | -100,00% | DOWN |
|
Tanke Biosciences OTCPK:TNBI |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | UP |
